Evaluation of a Training Model for the Proficient Use of the Belmont Rapid Infuser

NCT ID: NCT02059109

Last Updated: 2018-03-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2017-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Belmont Rapid Infuser is a device currently approved to replace larger volumes of necessary fluids such as blood in a fast and safe manner. The purpose of the study is to evaluate proficiency and the retention of knowledge of how to use the device based on current methods of training compared to revised training methods.

Hypotheses:

1. The use of the traditional method of training is not effective, predicting less then half of staff will pass on the first attempt.
2. Restructured test with hands-on training as opposed to oral presentation only with a written test will result in a pass rate of \> 80%.
3. Staff members who work in pairs will perform better than working alone when setting up the Belmont Rapid Infuser (BRI).
4. Retention at 3 months will be higher with the restructured training method than with the traditional training method.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be recruited to complete a test after undergoing either the traditional or the restructured training method. This training will be completed on one day and takes about 1 hour.

All participants who pass via either method of training are evaluated again to test retention 3-4 months later .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Use of the Belmont Rapid Infuser

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single

Staff will work alone to assemble the Belmont Rapid Infuser

Group Type EXPERIMENTAL

Hands on Assembly of Belmont Rapid Infuser

Intervention Type PROCEDURE

Participants will work individually or in pairs to assemble the Belmont Rapid Infuser in addition to completing the traditional training methods.

Pair

Staff will work in pairs to assemble the Belmont Rapid Infuser

Group Type EXPERIMENTAL

Hands on Assembly of Belmont Rapid Infuser

Intervention Type PROCEDURE

Participants will work individually or in pairs to assemble the Belmont Rapid Infuser in addition to completing the traditional training methods.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hands on Assembly of Belmont Rapid Infuser

Participants will work individually or in pairs to assemble the Belmont Rapid Infuser in addition to completing the traditional training methods.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants will be recruited from the faculty, Certified Registered Nurse Anesthetists, and fellows from the Department of Anesthesia at Cincinnati Children's Hospital Medical Center.
* They may have had educational exposure or use of the Belmont Rapid Infuser without independent assembly.

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Children's Hospital Medical Center, Cincinnati

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cincinnati Children's Medical Center

Cincinnati, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-1844

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Compass Device CVC Trial
NCT03056859 COMPLETED